Human VEGFR1/Flt-1 Quantikine ELISA Kit, NEW

• Reactivity: Hu
• Applications: ELISA
• Conjugate: HRP

Human VEGFR1/Flt-1 Quantikine ELISA Kit, NEW Summary

• Background: The Quantikine^® Human VEGF R1/Flt-1 Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human VEGF R1 in cell culture supernates, cell lysates, serum, plasma, and saliva. It contains NS0-expressed recombinant human VEGF R1 and has been shown to accurately quantitate the recombinant factor. Results obtained using natural human VEGF R1 showed linear curves that were par...allel to the standard curves obtained using the Quantikine^® kit standards. These results indicate that this kit can be used to determine relative mass values for natural human VEGF R1.
  
  Show More
• Specificity: Natural and recombinant human VEGF R1.
• Source: N/A
• Inter-Assay: See PDF Datasheet for details
• Intra-Assay: See PDF Datasheet for details
• Spike Recovery: See PDF Datasheet for details
• Sample Volume: See PDF Datasheet for details

Applications/Dilutions

• Dilutions:
  • ELISA
• Application Notes: No significant interference observed with available related molecules.

Packaging, Storage & Formulations

• Storage: Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Human VEGFR1/Flt-1 Quantikine ELISA Kit, NEW

• EC 2.7.10
• EC 2.7.10.1
• FLT
• FLT1
• Flt-1
• Fms-like tyrosine kinase 1
• fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascularpermeability factor receptor)
• FRT
• Tyrosine-protein kinase FRT
• Tyrosine-protein kinase receptor FLT
• vascular endothelial growth factor receptor 1
• Vascular permeability factor receptor
• VEGF R1
• VEGFR1
• VEGFR-1

Background

VEGF R1 (Flt-1), VEGF R2 (KDR/Flk-1), and VEGF R3 (Flt-4) belong to the class III subfamily of receptor tyrosine kinases (RTKs). All three receptors contain seven immunoglobulin-like repeats in their extracellular domain and kinase insert domains in their intracellular region. They are best known for regulating VEGF family-mediated vasculogenesis, angiogenesis, and lymphangiogenesis. They are also mediators of neurotrophic activity and regulators of hematopoietic development. VEGF R2 is thought to be the primary inducer of VEGF-mediated blood vessel growth, while VEGF R3 plays a significant role in VEGF-C and VEGF-D-mediated lymphangiogenesis.

⚠ WARNING: This product can expose you to chemicals including N,N-Dimethylforamide, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

Publications for VEGFR1/Flt-1 (DVR100C)(88)

Publications using DVR100C

• Moon, SY;Kim, HJ;Kim, JK;Kim, J;Choi, JS;Won, SY;Park, K;Lee, SHS; An examination of the mechanisms driving the therapeutic effects of an AAV expressing a soluble variant of VEGF receptor-1 PloS one 2024-07-11 [PMID: 38990973] (Human)
• Mäenpää, N;Tiainen, L;Hämäläinen, M;Luukkaala, T;Tanner, M;Lahdenperä, O;Vihinen, P;Karihtala, P;Kellokumpu-Lehtinen, PL;Moilanen, E;Jukkola, A; Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer BMC cancer 2024-03-11 [PMID: 38468231] (Human)
• Donohue, JK;Gruen, DS;Iyanna, N;Lorence, JM;Brown, JB;Guyette, FX;Daley, BJ;Eastridge, BJ;Miller, RS;Nirula, R;Harbrecht, BG;Claridge, JA;Phelan, HA;Vercruysse, GA;O'Keeffe, T;Joseph, B;Neal, MD;Billiar, TR;Sperry, JL; Mechanism matters: mortality and endothelial cell damage marker differences between blunt and penetrating traumatic injuries across three prehospital clinical trials Scientific reports 2024-02-02 [PMID: 38302619] (Human)
• Zhao, J;Duan, R;Sun, J;Chow, RP;Lyons, TJ;Yu, JY; An Examination of the Effect of Aspirin and Salicylic Acid on Soluble Fms-like Tyrosine Kinase-1 Release from Human Placental Trophoblasts Cells 2024-01-06 [PMID: 38247805] (Human)
• Pintye, D;Sziva, RE;Mastyugin, M;Young, BC;Jacas, S;Török, M;Salahuddin, S;Jagtap, P;Southan, GJ;Zsengellér, ZK; A Novel Dual-Function Redox Modulator Relieves Oxidative Stress and Anti-Angiogenic Response in Placental Villus Explant Exposed to Hypoxia-Relevance for Preeclampsia Therapy Biology 2023-09-12 [PMID: 37759628] (Human)
• Yang, Z;Jia, X;Deng, Q;Luo, M;Hou, Y;Yue, J;Mei, J;Shan, N;Wu, Z; Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with TFCP2 activate Wnt/?-catenin signaling to alleviate preeclampsia International immunopharmacology 2023-02-01 [PMID: 37724958] (Human)
• X Huang, L Jia, Y Jia, X Xu, R Wang, M Wei, H Li, H Peng, Y Wei, Q He, K Wang sFlt-1-enriched exosomes induced endothelial cell dysfunction and a preeclampsia-like phenotype in mice Cytokine, 2023-04-14;166(0):156190. 2023-04-14 [PMID: 37062152] (Human, Mouse)
• X Liu, Z Li, J Sun, Z Zhang, W Li Interaction between PD-L1 and soluble VEGFR1 in glioblastoma-educated macrophages BMC Cancer, 2023-03-20;23(1):259. 2023-03-20 [PMID: 36941554] (Human)
• LO Kurlak, PJ Scaife, LV Briggs, F Broughton, DS Gardner, HD Mistry Alterations in Antioxidant Micronutrient Concentrations in Placental Tissue, Maternal Blood and Urine and the Fetal Circulation in Pre-eclampsia International Journal of Molecular Sciences, 2023-02-10;24(4):. 2023-02-10 [PMID: 36834991] (Human)
• W Dymara-Kon, M Laskowska, E Grywalska, A Hymos, A B?a?ewicz, B Leszczy?sk Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction International Journal of Molecular Sciences, 2023-01-04;24(2):. 2023-01-04 [PMID: 36674486] (Human)
• J Kaur, K Kamboj, AK Yadav, P Kaur, V Kumar, V Jha Cholecalciferol supplementation and angiogenic markers in chronic kidney disease PLoS ONE, 2022-06-03;17(6):e0268946. 2022-06-03 [PMID: 35657784] (Human)
• EO Anto, DA Coall, EA Asiamah, OO Afriyie, O Addai-Mens, YA Wiafe, W Owiredu, C Obirikoran, ME Annani-Ako, NA Titiloye, E Adua, E Acheampong, EA Adu, S Opoku, AO Anto, A Tawiah, Y Wang, W Wang Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia PLoS ONE, 2022-03-21;17(3):e0265717. 2022-03-21 [PMID: 35312727] (Human)
• LA Fondjo, B Amoah, JJ Annan, EA Adu-Gyamfi, EA Asamaoh Hematobiochemical variability and predictors of new-onset and persistent postpartum preeclampsia Scientific Reports, 2022-03-04;12(1):3583. 2022-03-04 [PMID: 35246569] (Human)
• AM Nuzzo, L Moretti, P Mele, T Todros, C Eva, A Rolfo Effect of Placenta-Derived Mesenchymal Stromal Cells Conditioned Media on an LPS-Induced Mouse Model of Preeclampsia International Journal of Molecular Sciences, 2022-01-31;23(3):. 2022-01-31 [PMID: 35163594] (Human)
• H Wada, T Shinozaki, M Suzuki, S Sakagami, Y Ajiro, J Funada, M Matsuda, M Shimizu, T Takenaka, Y Morita, K Yonezawa, H Matsubara, Y Ono, T Nakamura, K Fujimoto, A Ninomiya, T Kato, T Unoki, D Takagi, K Wada, M Wada, M Iguchi, H Yamakage, T Kusakabe, A Yasoda, A Shimatsu, K Kotani, N Satoh-Asah, M Abe, M Akao, K Hasegawa, EXCEED?J S Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED-J Study Journal of the American Heart Association, 2022-01-20;11(3):e023464. 2022-01-20 [PMID: 35048713] (Human)
• JAF Silva, X Qi, MB Grant, ME Boulton Spatial and temporal VEGF receptor intracellular trafficking in microvascular and macrovascular endothelial cells Scientific Reports, 2021-08-30;11(1):17400. 2021-08-30 [PMID: 34462507] (Human)
• T Jia, T Jacquet, F Dalonneau, P Coudert, E Vaganay, C Exbrayat-H, J Vollaire, V Josserand, F Ruggiero, JL Coll, B Eymin FGF-2 promotes angiogenesis through a SRSF1/SRSF3/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells Bmc Biology, 2021-08-25;19(1):173. 2021-08-25 [PMID: 34433435] (Human)
• S Nabweyambo, OJ Sande, N McGovern, F Bwanga, A Ssekagiri, A Keesiga, M Adroma, R Wasswa, M Atuheirwe, J Namugenyi, B Castelnuov, A Nakimuli Circulating levels of angiogenic factors and their association with preeclampsia among pregnant women at Mulago National Referral Hospital in Uganda PLoS ONE, 2021-05-19;16(5):e0251227. 2021-05-19 [PMID: 34010327] (Human)
• S Kim, M Park, JY Kim, T Kim, JY Hwang, KS Ha, MH Won, S Ryoo, YG Kwon, YM Kim Circulating miRNAs Associated with Dysregulated Vascular and Trophoblast Function as Target-Based Diagnostic Biomarkers for Preeclampsia Cells, 2020-08-31;9(9):. 2020-08-31 [PMID: 32878300] (Human)
• RC Barbara, R Piotr, B Kornel, Z El?bieta, R Danuta, N Eduardo Divergent Impact of Breast Cancer Laterality on Clinicopathological, Angiogenic, and Hemostatic Profiles: A Potential Role of Tumor Localization in Future Outcomes J Clin Med, 2020-06-02;9(6):. 2020-06-02 [PMID: 32498398] (Human)
• DL Wilson, ME Howard, AM Fung, FJ O'Donoghue, M Barnes, M Lappas, SP Walker Sleep-disordered breathing does not impact maternal outcomes in women with hypertensive disorders of pregnancy PLoS ONE, 2020-04-27;15(4):e0232287. 2020-04-27 [PMID: 32339208] (Human)
• RA Rahman, P Murthi, H Singh, S Gurungsing, B Leaw, JC Mockler, R Lim, EM Wallace Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia Int J Mol Sci, 2020-04-03;21(7):. 2020-04-03 [PMID: 32260307] (Human)
• P Nikuei, M Rajaei, N Roozbeh, F Mohseni, F Poordarvis, M Azad, S Haidari Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia BMC Pregnancy Childbirth, 2020-02-07;20(1):80. 2020-02-07 [PMID: 32033594] (Human)
• FG Scurt, J Menne, S Brandt, A Bernhardt, PR Mertens, H Haller, C Chatzikyrk Systemic Inflammation Precedes Microalbuminuria in Diabetes Kidney Int Rep, 2019-06-21;4(10):1373-1386. 2019-06-21 [PMID: 31701047] (Human)
• MS Dias, VG Araujo, T Vasconcelo, Q Li, WW Hauswirth, R Linden, H Petrs-Silv Retina transduction by rAAV2 after intravitreal injection: comparison between mouse and rat Gene Ther., 2019-09-27;0(0):. 2019-09-27 [PMID: 31562387] (Mouse)
• E Zarychta, P Rhone, K Bielawski, M Michalska, D Ro??, B Ruszkowska Anti-angiogenic efficacy in invasive breast carcinoma patients depends on clinicopathological determinants Adv Med Sci, 2019-02-26;64(2):216-223. 2019-02-26 [PMID: 30818220] (Human)
• M Varas-Godo, S Acuña-Gall, S Venegas-Du, C Hill, A Caceres-Ve, O Realini, LJ Monteiro, G Zavala, M Khoury, R Romero, G Rice, SE Illanes Angiogenic Properties of Menstrual Stem Cells Are Impaired in Women with a History of Preeclampsia Stem Cells Int, 2019-01-27;2019(0):1916542. 2019-01-27 [PMID: 30809262] (Human)
• HW Unger, AP Hansa, C Buffet, W Hasang, A Teo, L Randall, M Ome-Kaius, S Karl, AA Anuan, JG Beeson, I Mueller, SJ Stock, SJ Rogerson Sulphadoxine-pyrimethamine plus azithromycin may improve birth outcomes through impacts on inflammation and placental angiogenesis independent of malarial infection Sci Rep, 2019-02-19;9(1):2260. 2019-02-19 [PMID: 30783215] (Human)
• C Abou Fayca, S Gazzeri, B Eymin A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells Sci Rep, 2019-01-23;9(1):336. 2019-01-23 [PMID: 30674935] (Human)
• P Villie, G Lefevre, R Arrestier, A Rousseau, N Berkane, A Hertig ELABELA concentration is not decreased in maternal plasma before the onset of preeclampsia Am. J. Obstet. Gynecol., 2018-12-18;220(3):284-285. 2018-12-18 [PMID: 30576665] (Human)
• SHS Lee, HJ Kim, OK Shin, JS Choi, J Kim, YH Cho, J Ha, TK Park, JY Lee, K Park, H Lee Intravitreal Injection of AAV Expressing Soluble VEGF Receptor-1 Variant Induces Anti-VEGF Activity and Suppresses Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., 2018-11-01;59(13):5398-5407. 2018-11-01 [PMID: 30452593] (Human)
• JA Sandgren, G Deng, DW Linggonego, SM Scroggins, KJ Perschbach, AR Nair, TE Nishimura, SY Zhang, LN Agbor, J Wu, HL Keen, MC Naber, NA Pearson, KA Zimmerman, RM Weiss, NC Bowdler, YM Usachev, DA Santillan, MJ Potthoff, GL Pierce, KN Gibson-Cor, CD Sigmund, MK Santillan, JL Grobe Arginine vasopressin infusion is sufficient to model clinical features of preeclampsia in mice JCI Insight, 2018-10-04;3(19):. 2018-10-04 [PMID: 30282823] (Mouse)
• JA Sullivan, LM Stanek, MJ Lukason, J Bu, SR Osmond, EA Barry, CR O'Riordan, LS Shihabuddi, SH Cheng, A Scaria Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain Gene Ther., 2018-05-22;0(0):. 2018-05-22 [PMID: 29785047] (Mouse, Rabbit)
• GS Stødle, GB Silva, LH Tangerås, LM Gierman, I Nervik, UE Dahlberg, C Sun, MH Aune, LCV Thomsen, L Bjørge, AC Iversen Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts Clin. Exp. Immunol., 2018-04-23;0(0):. 2018-04-23 [PMID: 29683202] (Human)
• H Tanaka, K Kumasawa, A Kakigano, K Mimura, M Endo, T Tomimatsu, T Kimura Arginase controls soluble vascular endothelial growth factor receptor 1 (sFlt1) to maintain pregnancy homeostasis Biochem. Biophys. Res. Commun., 2018-03-24;0(0):. 2018-03-24 [PMID: 29548823] (Human)
• H Li, J Yao, X Chang, J Wu, T Duan, K Wang LIFR increases the release of sEng via the up-regulation of MMP14 expression in PE Reproduction, 2018-01-23;0(0):. 2018-01-23 [PMID: 29363569] (Human)
• M Eslani, I Putra, X Shen, J Hamouie, N Afsharkham, S Besharat, MI Rosenblatt, R Dana, P Hematti, AR Djalilian Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1 Invest. Ophthalmol. Vis. Sci., 2017-10-01;58(12):5507-5517. 2017-10-01 [PMID: 29075761] (Human)
• M O'Brien, D Baczyk, JC Kingdom Endothelial Dysfunction in Severe Preeclampsia is Mediated by Soluble Factors, Rather than Extracellular Vesicles Sci Rep, 2017-07-19;7(1):5887. 2017-07-19 [PMID: 28725005] (Human)
• A Dutta, K Brito, G Khramstova, A Mueller, S Chinthala, D Alexander, D Adu, T Ibigbami, J Olamijulo, A Odetunde, K Adigun, L Pruitt, O Olopade, O Ojengbede, S Rana, CO Olopade Household air pollution and angiogenic factors in pregnant Nigerian women: A randomized controlled ethanol cookstove intervention Sci. Total Environ., 2017-05-29;599(0):2175-2181. 2017-05-29 [PMID: 28575932] (Human)
• AF Pantho, M Price, AZ Ashraf, U Wajid, ME Khansari, A Jahan, SH Afroze, MM Rhaman, CR Johnson, TJ Kuehl, MA Hossain, MN Uddin Synthetic Receptors Induce Anti Angiogenic and Stress Signaling on Human First Trimester Cytotrophoblast Cells Int J Environ Res Public Health, 2017-05-11;14(5):. 2017-05-11 [PMID: 28492503] (Human)
• VS Jammalamad, P Abraham Spectrum of Factors Triggering Endothelial Dysfunction in PIH J Clin Diagn Res, 2016-12-01;10(12):BC14-BC17. 2016-12-01 [PMID: 28208844] (Human)
• Shingo Takano The anti-angiogenic role of soluble-form VEGF receptor in malignant gliomas Int. J. Oncol, 2016-12-19;0(0):. 2016-12-19 [PMID: 28000842] (Human)
• Sushil Panta Low grade inflammation inhibits VEGF induced HUVECs migration in p53 dependent manner Biochem. Biophys. Res. Commun, 2016-12-18;0(0):. 2016-12-18 [PMID: 27998768] (Human)
• Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell Anemia PLoS ONE, 2016-09-26;11(9):e0162652. 2016-09-26 [PMID: 27669006] (Human)
• Ingrid C Weel Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia PLoS ONE, 2016-06-17;11(6):e0157584. 2016-06-17 [PMID: 27315098] (Human)
• Colby A. Souders, Sharon E. Maynard, Jing Yan, Yang Wang, Naomi K. Boatright, Jessica Sedan et al. Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia International Journal of Molecular Sciences 2015-06-02 [PMID: 26042465] (Human)
• Bessho H, Wong B, Huang D, Siew E, Huang D, Tan J, Ong C, Tan S, Matsumoto K, Iwamura M, Teh B Inhibition of placental growth factor in renal cell carcinoma. Anticancer Res, 2015-01-01;35(1):531-41. 2015-01-01 [PMID: 25550599] (Human)
• Sallinen H, Heikura T, Koponen J, Kosma V, Heinonen S, Yla-Herttuala S, Anttila M Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer. BMC Cancer, 2014-09-23;14(0):696. 2014-09-23 [PMID: 25245329] (Human)
• Owen , Leah A, Morrison , Margaux, Ahn , Jeeyun, Woo , Se Joon, Sato , Hajime, Robinson , Rosann, Morgan , Denise J, Zacharaki , Fani, Simeonova , Marina, Uehara , Hironori, Chakravarthy , Usha, Hogg , Ruth E, Ambati , Balamura, Kotoula , Maria, Baehr , Wolfgang, Haider , Neena B, Silvestri , Giuliana, Miller , Joan W, Tsironi , Evangeli, Farrer , Lindsay, Kim , Ivana K, Park , Kyu Hyun, DeAngelis , Margaret FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression. Invest Ophthalmol Vis Sci, 2014-05-08;55(6):3543-54. 2014-05-08 [PMID: 24812550] (Human)
• White W, Garrett A, Craici I, Wagner S, Fitz-Gibbon P, Butters K, Brost B, Rose C, Grande J, Garovic V Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury. PLoS ONE, 2014-03-24;9(3):e92693. 2014-03-24 [PMID: 24664365] (Human)
• Necchi A, Pennati M, Zaffaroni N, Landoni E, Giannatempo P, Raggi D, Schwartz L, Morosi C, Crippa F, Fare E, Nicolai N, Lanocita R, Sava T, Sacco C, Messina C, Ortega C, De Braud F, Salvioni R, Daidone M, Gianni A, Mariani L Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy. Br J Cancer, 2013-11-14;110(1):26-33. 2013-11-14 [PMID: 24231947] (Human)
• Liu , Linda Y, Yang , Ting, Ji , Jun, Wen , Qiaojun, Morgan , Alexande, Jin , Bo, Chen , Gongxing, Lyell , Deirdre, Stevenson , David K, Ling , Xuefeng, Butte , Atul J Integrating multiple 'omics' analyses identifies serological protein biomarkers for preeclampsia. BMC Med, 2013-11-06;11(0):236. 2013-11-06 [PMID: 24195779] (Human)
• El-Tarhouny S, Almasry S, Elfayomy A, Baghdadi H, Habib F Placental growth factor and soluble Fms-like tyrosine kinase 1 in diabetic pregnancy: A possible relation to distal villous immaturity. Histol Histopathol, 2013-08-13;29(2):259-72. 2013-08-13 [PMID: 23939615] (Human)
• Justiniano S, Elavazhagan S, Fatehchand K, Shah P, Mehta P, Roda J, Mo X, Cheney C, Hertlein E, Eubank T, Marsh C, Muthusamy N, Butchar J, Byrd J, Tridandapani S Fcgamma receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies. J Biol Chem, 2013-07-31;288(37):26800-9. 2013-07-31 [PMID: 23902770] (Human)
• Huang Q, Wang S, Zhang M, Huang L, Tian J, Yu Y, Wang Z, Zhong M Advanced oxidation protein products enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia. Placenta, 2013-07-27;34(10):949-52. 2013-07-27 [PMID: 23899470] (Human)
• Suzuki T, Shimada H, Makizako H, Doi T, Yoshida D, Ito K, Shimokata H, Washimi Y, Endo H, Kato T A randomized controlled trial of multicomponent exercise in older adults with mild cognitive impairment. PLoS ONE, 2013-04-09;8(4):e61483. 2013-04-09 [PMID: 23585901] (Human)
• Braicu E, Fotopoulou C, Chekerov R, Richter R, Blohmer J, Kummel S, Stamatian F, Yalcinkaya I, Mentze M, Lichtenegger W, Sehouli J Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: results of a companion protocol of the randomized, NOGGO-AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapy. Cytokine, 2013-02-14;61(3):755-8. 2013-02-14 [PMID: 23415672] (Human)
• Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, Tudorache I, Bauersachs J, del Monte F, Hilfiker-Kleiner D, Karumanchi SA, Arany Z Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature, 2012-05-09;485(7398):333-8. 2012-05-09 [PMID: 22596155] (Human)
• Landt S, Heidecke H, Korlach S, Reuter C, Schwidde I, Barinoff J, Thill M, Sehouli J, Kummel S In vitro vascular tube formation testing as a tool for treatment individualisation in patients with cervical cancer. Anticancer Res., 2011-08-01;31(8):2609-15. 2011-08-01 [PMID: 21778312] (Human)
• Landt S, Wehling M, Heidecke H, Jeschke S, Korlach S, Stoblen F, Schmid P, Blohmer JU, Lichtenegger W, Sehouli J, Kummel S Prognostic significance of angiogenic factors in uterine cervical cancer. Anticancer Res., 2011-08-01;31(8):2589-95. 2011-08-01 [PMID: 21778309] (Human)
• Rahbari NN, Schmidt T, Falk CS, Hinz U, Herber M, Bork U, Buchler MW, Weitz J, Koch M Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer. BMC Cancer, 2011-07-05;11(0):286. 2011-07-05 [PMID: 21729304] (Human)
• Dubois SG, Shusterman S, Ingle AM, Ahern CH, Reid JM, Wu B, Baruchel S, Glade-Bender J, Ivy P, Grier HE, Adamson PC, Blaney SM Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study. Clin. Cancer Res., 2011-06-20;17(15):5113-22. 2011-06-20 [PMID: 21690570] (Human)
• Jeyabalan A, Powers RW, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M, Caritis S, Roberts JM, Kuller J, Cotroneo M, Kamon T, Mercer B, Ramsey R, Paul R, Rabello Y, McCart D, Mueller E, Goldenberg R, Copper R, Sorokin Y, Norman G, Millinder A, Christmas JT, McCoy S, Elder S, Elder N, Carter B, Pemberton V, Thurnau G, Meier A, Minton V, Meis P, Swain M, Moawad AH, Jones P, Iams JD, Meadows S, Brenner S, Collins B, Newman RB, Carter SG, Romero R, Sabo V, Thom E, Bain RP, MacPherson C, Johnson D, Fischer ML, McNellis D, Spong C, Catz C, Yaffe S Effect of smoking on circulating angiogenic factors in high risk pregnancies. PLoS ONE, 2010-10-12;5(10):e13270. 2010-10-12 [PMID: 20967275] (Human)
• Powers RW, Jeyabalan A, Clifton RG Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS ONE, 2010-10-11;5(10):e13263. 2010-10-11 [PMID: 20948996] (Human)
• Jeevaratnam K, Nadarajah VD, Judson JP Periodic assessment of plasma sFlt-1 and PlGF concentrations and its association with placental morphometry in gestational hypertension (GH) - a prospective follow-up study. BMC Pregnancy Childbirth, 2010-09-28;10(0):58. 2010-09-28 [PMID: 20920154] (Human)
• Kosugi T, Nakayama T, Li Q, Chiodo VA, Zhang L, Campbell-Thompson M, Grant M, Croker BP, Nakagawa T Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice. Am. J. Physiol. Renal Physiol., 2009-12-16;298(3):F609-16. 2009-12-16 [PMID: 20015944] (Human)
• Levine RJ, Vatten LJ, Horowitz GL Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study. BMJ, 2009-11-17;339(0):b4336. 2009-11-17 [PMID: 19920004] (Human)
• Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am. J. Obstet. Gynecol., 2009-10-21;202(2):161.e1-161.e1. 2009-10-21 [PMID: 19850276] (Human)
• Bourlev V, Iljasova N, Adamyan L, Larsson A, Olovsson M Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis. Fertil. Steril., 2009-03-25;94(1):52-7. 2009-03-25 [PMID: 19324337] (Human)
• Sandhofer A, Tatarczyk T, Kirchmair R, Iglseder B, Paulweber B, Patsch JR, Schratzberger P Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study. Atherosclerosis, 2009-02-03;206(1):265-9. 2009-02-03 [PMID: 19237157] (Human)
• Sallinen H, Anttila M, Narvainen J, Koponen J, Hamalainen K, Kholova I, Heikura T, Toivanen P, Kosma VM, Heinonen S, Alitalo K, Yla-Herttuala S Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice. Mol. Ther., 2008-12-02;17(2):278-84. 2008-12-02 [PMID: 19050699] (Human)
• Muehlenbachs A, Fried M, Lachowitzer J, Mutabingwa TK, Duffy PE Natural selection of FLT1 alleles and their association with malaria resistance in utero. Proc. Natl. Acad. Sci. U.S.A., 2008-09-08;105(38):14488-91. 2008-09-08 [PMID: 18779584] (Human)
• Findley CM, Mitchell RG, Duscha BD, Annex BH, Kontos CD Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J. Am. Coll. Cardiol., 2008-07-29;52(5):387-93. 2008-07-29 [PMID: 18652948] (Human)
• Jeyabalan A, Powers RW, Durica AR, Harger GF, Roberts JM, Ness RB Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am. J. Hypertens., 2008-06-19;21(8):943-7. 2008-06-19 [PMID: 18566591] (Human)
• Gutman G, Barak V, Maslovitz S, Amit A, Lessing JB, Geva E Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis. Fertil. Steril., 2008-03-17;89(4):922-6. 2008-03-17 [PMID: 18343373] (Human)
• Clavel G, Bessis N, Lemeiter D, Fardellone P, Mejjad O, Menard JF, Pouplin S, Boumier P, Vittecoq O, Le Loet X, Boissier MC Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin. Immunol., 2007-06-08;124(2):158-64. 2007-06-08 [PMID: 17560831] (Human)
• Caine GJ, Ryan P, Lip GY, Blann AD Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients. Cancer Lett., 2007-01-19;251(2):296-301. 2007-01-19 [PMID: 17240049] (Human)
• Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med., 2006-09-07;355(10):992-1005. 2006-09-07 [PMID: 16957146] (Human)
• Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, Schlembach D Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin. Sci., 2007-01-01;112(1):51-7. 2007-01-01 [PMID: 16928195] (Human)
• Caine GJ, Stonelake PS, Lip GY, Blann AD Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer. Cancer Lett., 2006-08-07;248(1):131-6. 2006-08-07 [PMID: 16891056] (Human)
• Masuyama H, Suwaki N, Nakatsukasa H, Masumoto A, Tateishi Y, Hiramatrsu Y Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Am. J. Obstet. Gynecol., 2006-02-01;194(2):551-6. 2006-02-01 [PMID: 16458660] (Human)
• Mross K, Drevs J, Muller M, Medinger M, Marme D, Hennig J, Morgan B, Lebwohl D, Masson E, Ho YY, Gunther C, Laurent D, Unger C Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours. Eur. J. Cancer, 2005-06-01;41(9):1291-9. 2005-06-01 [PMID: 15939265] (Human)
• Buhimschi CS, Norwitz ER, Funai E, Richman S, Guller S, Lockwood CJ, Buhimschi IA Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am. J. Obstet. Gynecol., 2005-03-01;192(3):734-41. 2005-03-01 [PMID: 15746665] (Human)
• Li H, Gu B, Zhang Y, Lewis DF, Wang Y Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta, 2005-02-01;26(2):210-7. 2005-02-01 [PMID: 15708122] (Human)
• Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, Blink AL, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA Urinary placental growth factor and risk of preeclampsia. JAMA, 2005-01-05;293(1):77-85. 2005-01-05 [PMID: 15632339] (Human)
• Eubank TD, Roberts R, Galloway M, Wang Y, Cohn DE, Marsh CB GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice. Immunity, 2004-12-01;21(6):831-42. 2004-12-01 [PMID: 15589171] (Human)
• Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med., 2004-02-05;350(7):672-83. 2004-02-05 [PMID: 14764923] (Human)
• Maynard SE, Min JY, Merchan J, Lim KH, Mondal S, Stillman IE, Epstein FH, Karumanchi SA Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest., 2003-03-01;111(5):649-58. 2003-03-01 [PMID: 12618519] (Human)